These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32767188)

  • 1. Oxidative/Nitroxidative Stress and Multiple Sclerosis.
    Tobore TO
    J Mol Neurosci; 2021 Mar; 71(3):506-514. PubMed ID: 32767188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria-targeted Antioxidants as a Prospective Therapeutic Strategy for Multiple Sclerosis.
    Fetisova E; Chernyak B; Korshunova G; Muntyan M; Skulachev V
    Curr Med Chem; 2017; 24(19):2086-2114. PubMed ID: 28302008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis.
    Rajda C; Pukoli D; Bende Z; Majláth Z; Vécsei L
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidants in multiple sclerosis: do they have a role in therapy?
    Carlson NG; Rose JW
    CNS Drugs; 2006; 20(6):433-41. PubMed ID: 16734496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis.
    Adamczyk B; Adamczyk-Sowa M
    Oxid Med Cell Longev; 2016; 2016():1973834. PubMed ID: 27829982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights in the mechanisms of impaired redox signaling and its interplay with inflammation and immunity in multiple sclerosis.
    Michaličková D; Šíma M; Slanař O
    Physiol Res; 2020 Feb; 69(1):1-19. PubMed ID: 31852206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a comprehensive etiopathogenetic and pathophysiological theory of multiple sclerosis.
    Tobore TO
    Int J Neurosci; 2020 Mar; 130(3):279-300. PubMed ID: 31588832
    [No Abstract]   [Full Text] [Related]  

  • 8. Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis.
    Wang P; Xie K; Wang C; Bi J
    Eur Neurol; 2014; 72(3-4):249-54. PubMed ID: 25277682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis.
    Haider L
    Oxid Med Cell Longev; 2015; 2015():725370. PubMed ID: 26106458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis.
    Miller ED; Dziedzic A; Saluk-Bijak J; Bijak M
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31284389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in antioxidative therapy of multiple sclerosis.
    Miller E; Wachowicz B; Majsterek I
    Curr Med Chem; 2013; 20(37):4720-30. PubMed ID: 23834174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria in multiple sclerosis.
    Ghafourifar P; Mousavizadeh K; Parihar MS; Nazarewicz RR; Parihar A; Zenebe WJ
    Front Biosci; 2008 Jan; 13():3116-26. PubMed ID: 17981781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical changes in multiple sclerosis pathogenesis.
    van Horssen J; Witte ME; Schreibelt G; de Vries HE
    Biochim Biophys Acta; 2011 Feb; 1812(2):141-50. PubMed ID: 20600869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress involvement in the molecular pathogenesis and progression of multiple sclerosis: a literature review.
    Sanabria-Castro A; Alape-Girón A; Flores-Díaz M; Echeverri-McCandless A; Parajeles-Vindas A
    Rev Neurosci; 2024 Apr; 35(3):355-371. PubMed ID: 38163257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology and oxidative stress in multiple sclerosis: clinical and basic approach.
    Ortiz GG; Pacheco-Moisés FP; Bitzer-Quintero OK; Ramírez-Anguiano AC; Flores-Alvarado LJ; Ramírez-Ramírez V; Macias-Islas MA; Torres-Sánchez ED
    Clin Dev Immunol; 2013; 2013():708659. PubMed ID: 24174971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress in multiple sclerosis: Central and peripheral mode of action.
    Ohl K; Tenbrock K; Kipp M
    Exp Neurol; 2016 Mar; 277():58-67. PubMed ID: 26626971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating inflammation and neuroprotection in multiple sclerosis.
    Yong H; Chartier G; Quandt J
    J Neurosci Res; 2018 Jun; 96(6):927-950. PubMed ID: 28580582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis.
    Witte ME; Mahad DJ; Lassmann H; van Horssen J
    Trends Mol Med; 2014 Mar; 20(3):179-87. PubMed ID: 24369898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis: lessons from molecular neuropathology.
    Lassmann H
    Exp Neurol; 2014 Dec; 262 Pt A():2-7. PubMed ID: 24342027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.